This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo

Sodium feredetate oral

Updated 2 Feb 2023 | Oral iron

Presentation

Oral formulation of sodium feredetate.

Drugs List

  • sodium feredetate 27.5mg/5ml (as iron) oral solution sugar-free
  • SYTRON 27.5mg/5ml (as iron) oral solution
  • Therapeutic Indications

    Uses

    Prophylaxis of iron deficiency anaemia
    Treatment of iron deficiency anaemia

    Dosage

    Adults

    Therapeutic dose
    5ml (27.5mg of elemental iron) increasing gradually to 10ml three times daily.

    Children

    Therapeutic dose
    3 to 6mg/kg (max 200mg) of elemental iron daily given in 2 to 3 divided doses.

    Alternative sources suggest the following dosage:
    Children aged 12 to 18 years:5ml three times daily, increased gradually to 10ml three times daily.
    Children aged 5 to 12 years:5ml three times daily.
    Children aged 1 to 5 years:2.5ml three times daily.
    Children aged 1 month to 1 year:Up to 2.5ml twice daily.

    Prophylactic dose
    Children aged 12 to 18 years
    60mg of elemental iron.
    Children aged 6 to 12 years
    30mg to 60mg of elemental iron.
    Children aged 2 to 6 years
    20mg to 30mg of elemental iron.
    Children aged 6 to 24 months
    12.5mg of elemental iron.

    Alternative sources suggest the following dosage:
    Children aged 1 month to 1 year: 1ml daily. Prophylactic iron supplementation may be required in babies of low birth-weight who are solely breast-fed. Supplementation is started 4 to 6 weeks after birth and continued until mixed feeding is established.

    Neonates

    Therapeutic dose
    Alternative sources suggest the following:
    Up to 2.5ml twice daily. Initially smaller doses are recommended.

    Prophylactic dose
    Babies of low birth weight who are solely breast-fed:
    5mg daily of elemental iron is recommended. Higher doses up to 2mg/kg of elemental iron per day might be needed to cover the needs of growing exclusively breastfed infants. Supplementation is started 4 to 6 weeks after birth and continued until mixed feeding is established.

    Contraindications

    Haemochromatosis
    Haemosiderosis
    Hereditary fructose intolerance
    Repeated blood transfusions

    Precautions and Warnings

    Restricted sodium intake
    Gastrointestinal disorder
    Haemolytic anaemia

    Sodium content of formulation may be significant
    Exclude non-iron deficiency anaemia
    Contains alcohol
    Contains hydroxybenzoate
    Contains ponceau 4R (E124) - may cause allergic reactions
    Presentations with sorbitol unsuitable in hereditary fructose intolerance
    May affect results of some laboratory tests
    Children: Avoid prolonged or excessive use
    Advise patient stools may be discoloured
    Advise patient to take after food to reduce gastro-intestinal disturbances

    Pregnancy and Lactation

    Pregnancy

    Sodium feredetate is considered safe for use during pregnancy.

    Manufacturer advises that no adverse effects have been reported during use in pregnancy.

    Lactation

    Sodium feredetate is considered safe for use during breastfeeding.

    Manufacturer advises that no adverse effects have been reported in breastfeeding.

    Side Effects

    Discolouration of stools
    Hypersensitivity reactions
    Mild diarrhoea
    Nausea

    Overdosage

    It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.

    The following number will direct the caller to the relevant local centre (0844) 892 0111

    Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).

    Further Information

    Last Full Review Date: March 2020

    Reference Sources

    Summary of Product Characteristics: Sytron 27.5mg iron per 5 ml Oral Solution. Kyowa Kirin Limited. Revised November 2019.

    NICE Evidence Services Available at: www.nice.org.uk Last accessed: 21 February 2020

    Access the full UK drug database with a FREE Medscape UK Account
    It takes just a few minutes, and you’ll get unlimited access to information on over 11,000 UK drugs.
    Register for Free

    Already a member? Log in

    Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content

    FDB Logo

    FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.